You are seeing these quotes based on previous browsing related to sectors such as
Latest | Forecast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | 0.0% | -100.4% |
ROCE | 910.4% |
Latest | Forecast | |
---|---|---|
P/E | -3.3 | 0.0 |
PEG | 0.0 | -999,999.0 |
Price / Revenue | 0.0 | 5.5 |
Price / Book value | -7.3 |
Latest | Forecast | |
---|---|---|
Revenue | 0.0% | -15.6% |
PBT | 0.0% | n/a |
EPS | 0.0% | -64.9% |
DPS | n/a | 0.0% |
Year Ending | Revenue (€m) |
Pre-tax (€m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
---|---|---|---|---|---|---|---|---|
2019-12-31 | n/a | -13.25 | €-0.36 | -8.6 | 0.0 | n/a | n/a | 0.0% |
2020-12-31 | n/a | -16.93 | €-0.37 | -7.9 | 0.0 | n/a | n/a | 0.0% |
2021-12-31 | n/a | -21.18 | €-0.42 | -7.6 | 0.0 | n/a | n/a | 0.0% |
2022-12-31 | 0.00 | -28.73 | €-0.52 | -6.5 | 0.0 | n/a | n/a | 0.0% |
2023-12-31 | 0.00 | -30.94 | €-0.48 | -7.3 | 0.0 | n/a | n/a | 0.0% |
Faron shares jump on encouraging trial data Sharecast News | 18 Mar |
---|---|
Faron Pharmaceuticals reports year of clinical progress Sharecast News | 13 Mar |
Faron Pharmaceuticals shores up cash with EUR 3.2m convertible loans Sharecast News | 04 Mar |
Issue of Warrants to IPF Funding Update | 28-Mar-24 07:01 |
---|---|
Faron´s Annual Report 2023 | 26-Mar-24 10:03 |
Additional Positive Data from Phase 1 of BEXMAB | 18-Mar-24 07:01 |
Notice of Annual General Meeting 2024 | 13-Mar-24 14:01 |
Financial Statement January 1 to December 31 2023 | 13-Mar-24 07:00 |